Hepatitis C News and Research

RSS
Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.

The hepatitis C virus is usually transmitted through contact with the blood of an infected individual and, most commonly, people catch it through sharing contaminated needles when injecting illegal drugs.

Hepatitis C infection is categorized into an acute and a chronic stage. The acute phase describes the first 6 months of infection when there are not necessarily any symptoms. Around one quarter of people manage to clear the infection during this stage before disease progresses to the chronic stage.

People who go on to develop chronic hepatitis C may develop jaundice which turns the skin and whites of the eyes yellow. This is caused by the build-up of a yellow-colored substance in the blood called bilirubin that would usually be broken down by the liver if it was healthy. Chronic infection may eventually cause fibrosis and scarring (cirrhosis) of the liver, liver cancer or end stage liver failure.

Hepatitis C can be treated with antiviral medications that that are designed to disrupt the multiplication of virus particles inside the body and prevent liver damage.
Research provides insight into molecular mechanisms involved in immune response to HBV

Research provides insight into molecular mechanisms involved in immune response to HBV

New public-private partnership launches major health effort to reduce cancer in San Francisco

New public-private partnership launches major health effort to reduce cancer in San Francisco

Molecules team up to maintain healthy level of fat in liver, study finds

Molecules team up to maintain healthy level of fat in liver, study finds

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

Suppressed vaginal immune response makes women more susceptible to RNA viruses

Suppressed vaginal immune response makes women more susceptible to RNA viruses

Eminent physician Kenneth Walker receives Georgia Hospital Heroes Lifetime Achievement Award

Eminent physician Kenneth Walker receives Georgia Hospital Heroes Lifetime Achievement Award

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors linked to lower odds of developing liver diseases

New technology uses USB stick to monitor HIV in bloodstream

New technology uses USB stick to monitor HIV in bloodstream

TSRI researchers uncover mechanism behind T cell exhaustion

TSRI researchers uncover mechanism behind T cell exhaustion

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Over 1 million people treated with revolutionary hepatitis C medicines

Over 1 million people treated with revolutionary hepatitis C medicines

Poor, remote Indigenous Australians have increased risk of sexually transmissible infections

Poor, remote Indigenous Australians have increased risk of sexually transmissible infections

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

TSRI scientists discover reason for lack of successful HCV vaccine design

TSRI scientists discover reason for lack of successful HCV vaccine design

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test